Sarepta Therapeutics | SRPT - Mitarbeiter Gesamtzahl

Aktienkurs
20.30
Täglich Wechseln
-0.12 -0.59%
Monatlich
-14.60%
Jährlich
-66.41%
Q2 Prognose
19.87




Mitarbeiter Veränderung Datum
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amgen 28K 1.3K 2024-12
BioCryst Pharmaceuticals 536 5 2023-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Capricor Therapeutics 101 27 2023-12
Daiichi Sankyo 19.76K 1.04K 2025-12
Eli Lilly 47K 4K 2024-12
Esperion Therapeutics 240 41 2023-12
Gilead Sciences 17.6K 400 2024-12
Incyte 2.62K 93 2024-12
Insmed 1.27K 359 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Moderna 5.8K 200 2024-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Novavax 1.54K 449 2023-12
Pfizer 81K 7K 2024-12
PTC Therapeutics 939 49 2024-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sangamo BioSciences 405 73 2023-12
Sanofi 84.59K 3.41K 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
Tectonic Therapeutic 45 1 2023-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12